𝔖 Bobbio Scriptorium
✦   LIBER   ✦

LONG-TERM TREATMENT WITH A NEW NON-ERGOT LONG-ACTING DOPAMINE AGONIST, CV 205-502, IN WOMEN WITH HYPERPROLACTINAEMIA

✍ Scribed by CARSTEN RASMUSSEN; TORBJÖRN BERGH; LEIF WIDE; JUDITH BROWNELL


Book ID
114718793
Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
539 KB
Volume
29
Category
Article
ISSN
0300-0664

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Antiparkinsonian activity of a non-ergot
✍ Dr. W. Poewe; G. Luef; B. Kleedorfer; M. Emre 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB

## Abstract Six patients with fluctuating Parkinson's disease received single rising oral doses of the nonergot dopamine agonist CV 205‐502 in an open experimental study. Doses of 0.5 mg produced antiparkinsonian effects of comparable intensity but longer duration than 200 mg of L‐DOPA. CV 205‐502,